Background: Microfracture is commonly performed for cartilage repair but usually results in fibrocartilage. Microfracture
C
hondral injuries contribute to progressive articular cartilage loss and the eventual development of osteoarthritis [1] [2] [3] , a major public health issue 4, 5 . Articular cartilage has limited capacity to repair lesions that do not extend into the underlying bone 6, 7 . Strategies to improve cartilage repair are therefore important in the effort to reduce the disease burden of osteoarthritis.
Microfracture is widely used to access bone marrow cells for cartilage repair 8, 9 . While considered a clinical standard 10, 11 , microfracture has variable clinical outcomes [12] [13] [14] [15] . Among professional athletes, results after microfracture range from the resumption of high-performance sports to continued disability [16] [17] [18] [19] . Variability in the amount and quality of cartilage-repair tissues, along with the observation of subchondral bone changes after microfracture, has also been reported 15, [20] [21] [22] . Recently, surgical compromise of the subchondral bone has been postulated to negatively affect subsequent treatment with other cartilage-repair techniques 14, 15, 20, 21 .
The amount and quality of repair cells available to the cartilage wound also remain key variables in the success or failure of bone marrow cell-based cartilage repair. Marrow stimulation accesses local bone marrow cells 7, 8, 21 . Bone marrow aspirate (BMA) can be obtained from sites with higher concentrations of mesenchymal cells, such as the iliac crest in humans or the sternum in an equine model, and centrifuged at the point of care to concentrate potential reparative cells 23, 24 . Human clinical studies have shown that autologous bone marrow concentrate (BMC) suspended in collagen or hyaluronic acid scaffolds supports repair of fullthickness chondral defects [25] [26] [27] . Prior work in an equine model showed that augmentation of microfracture with BMC resulted in structurally and biochemically improved cartilage repair compared with microfracture alone 23 . To address concerns about potential undesired subchondral bone changes after microfracture, we performed the current study to test the hypothesis that arthroscopically applied BMC without concomitant microfracture improves fullthickness chondral defect repair compared with microfracture alone.
Materials and Methods
A ll equine care and investigational procedures were performed at Cornell University according to Institutional Animal Care and Use Committee-approved protocols. Horse sternal BMA was collected in the operating room from 8 young adult horses (3 castrated male and 5 female, 2 to 4 years of age). A 60-mL aliquot of BMA from each horse was processed using SmartPrep 2 BMAC (Harvest Technologies) according to the manufacturer's protocol. One horse was lost to follow-up for reasons unrelated to the study. The repair tissues from the remaining 7 horses were analyzed by arthroscopic, magnetic resonance imaging (MRI), and histological assessments 1 year after surgery.
Equine Chondral Defect and Repair Models
Full-thickness, critical-sized 28 chondral defects were created arthroscopically in the midlateral trochlear ridge of bilateral stifles by experienced equine surgeons (L.A.F., T.M.M.) using a 15-mmdiameter cutter according to a previously described technique 23 .
Calcified cartilage was removed with a curette. After defect creation, 1 limb of each animal was randomly assigned to receive microfracture treatment using a standard microfracture awl to puncture the subchondral plate within the lesion bed in a standardized pattern. The contralateral limbs were switched to CO 2 for joint distension, after which the chondral lesions were dried. BMC mixed 10:1 with bovine thrombin and calcium chloride to form a clot was then arthroscopically applied directly into the dried defect. CO 2 arthroscopy was maintained until clotting was observed. Full joint range of motion was then tested to visually verify BMC clot stability within the defect.
The horses were returned to free stall activity immediately after surgery. An incremental walking program was initiated 2 weeks after surgery. Free pasture exercise was permitted 3.5 Majority rounded/chondrogenic 3 *Minimum score = 0, and maximum score = 9. †Section 3 to 4 mm thick.
months after surgery, until study completion. Gait examinations made prior to surgery and before euthanasia showed no gait asymmetries at either time point.
In Vitro Assessments Samples of BMA, BMC, and Ficoll gradient isolates of BMA from 7 horses were evaluated. From each sample, 300,000 cells/cm 2 were plated on standard tissue culture plates in growth media 29 . Total cell counts were obtained at first passage after 14 days of culture. The chondrogenic potential of freshly isolated and culture-expanded cells was tested using a previously described 3-dimensional (3-D) pellet culture assay 30 for evaluating pellet formation after transforming growth factorbeta 1 (TGF-b1) stimulation. Chondrogenesis was assessed by pellet area, safranin O-fast green staining, and histological grading with the Bern score 30, 31 . The Bern score (Table I ) evaluates the uniformity and intensity of safranin O stain; the distance between cells, reflecting the amount of matrix; and cell morphology 31 . Monolayer cultures of cells from the BMA, BMC, and Ficoll groups were tested for osteogenesis by alizarin red staining and for adipogenesis, by oil red O staining.
Arthroscopic Evaluation
Cartilage repairs were arthroscopically assessed and video recorded at the 1-year follow-up by an experienced orthopaedic surgeon blinded to the treatment group (C.R.C.). Two experienced surgeons (C.R.C. and L.A.F.) graded the deidentified videos using the International Cartilage Repair Society (ICRS) macroscopic evaluation scoring system (scale of 0 to 12, where 12 is normal) 32 . The repairs were independently scored by the 2 blinded graders, who then derived consensus scores for the percent of defect repair, integration into the border zone, macroscopic appearance, and overall assessment. 140
Morphological MRI Intact stifles underwent 3-T MRI evaluations using a 3-D double-echo steady-state (DESS; Siemens Medical Solutions) sequence with water excitation and with settings as follows: 14-cm field of view, 0.7-mm slice thickness, in-plane resolution of 437 · 437 mm, and TR (repetition time) and TE (echo time) of 16.4 and 4.9 ms. The DESS images were graded on the basis of repair tissue fill, subchondral bone overgrowth, subchondral sclerosis, and synovial reaction 23 by a musculoskeletal radiologist (D.J.) who was blinded to the treatment groups (Table II) . Synovial reaction was assessed as the area of high signal intensity in the soft tissues adjacent to the cartilage judged to be focal synovitis by the experienced radiologist (D.J.).
Quantitative MRI
The explanted lateral trochlear ridge was mounted on an acrylic registration plate for axial T2-weighted and ultrashort echo time enhanced T2* (UTE-T2*) MRI mapping using a 3-T MRI scanner (Siemens Medical Solutions) with an 8-channel knee coil (Invivo). Axial T2-weighted images were acquired using a multi-echo, multi-slice spin-echo sequence with 7 echoes (TE = 11, 22, 33, 44, 55, 66, and 77 ms) and with a TR of 1,800 ms, in-plane resolution of 313 · 313 mm, and 2-mm slice thickness. Axial 3-D acquisition-weighted stack of spirals (AWSOS) images [33] [34] [35] were acquired at 10 echo times (TE = 0.6, 1, 2, 3, 4, 5, 7, 10, 20, and 28 ms) and with in-plane resolution of 234 · 234 mm and 2-mm slice thickness.
T2 and UTE-T2* MRI maps were calculated from an axial slice through the center of the repair. A region of interest was manually drawn on each fitted map to encompass the fullthickness depth and width of the cartilage repair. Mean T2 and UTE-T2* values were recorded for each region of interest.
Cartilage matrix organization was measured on the calculated T2 and UTE-T2* maps using gray-level co-occurrence matrix (GLCM) second-order texture statistics from in-house developed software running on a MATLAB platform (MathWorks) 36, 37 . Four statistical features ("contrast," "homogeneity," "correlation," and "energy"), calculated as previously reported (Fig. 2-b ) and 1 BMC (Fig. 2-d ) repair, and thin repair tissues in 2 microfracture repairs (Figs. 2-b and 2-c) and 1 BMC repair (Fig. 2-d) . Quantitative MRI techniques such as UTE-T2* mapping (Figs. 2-a through 2-f) provide additional information on repair tissue subsurface matrix structure measured through texture analysis that may not be readily apparent on visual inspection. . This qualitative interpretation is reflected in the overall texture analysis of UTE-T2* maps, which showed greater "contrast," less "homogeneity," and less "energy" for BMC repairs compared with microfracture. Hematoxylin and eosin staining (Figs. 3-E and 3-K) demonstrates deep to full-thickness tissue voids and fissures (arrow) as well as deep-tissue heterogeneity and a bone void (arrowhead) below the repair treated with microfracture ( Fig. 3-E) . The hematoxylin and eosin staining of the BMC repair shows incomplete integration (arrow) with more intact deep tissue and no bone void (Fig. 3-K) . Safranin O-fast green staining shows no substantial proteoglycan in the repair tissues (Figs. 3-F and 3-L) .
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T 17, 2018 were investigated at a 1-pixel offset perpendicular (90°) to the repair tissue surface.
Histological Assessment
Osteochondral slabs were fixed, decalcified, embedded in paraffin, sectioned, and stained with hematoxylin and eosin and safranin O-fast green. The de-identified stained sections were consensus-scored by 2 graders (L.A.F. and M.E.B.) according to the ICRS Visual Histological Assessment Scale (scale of 0 to 18, with 18 being normal) 38 to evaluate surface integrity, matrix structure, cell distribution, and population viability as well as subchondral bone and cartilage mineralization.
Statistical Methods
Data were examined with Shapiro-Wilk tests to assess the normality of the distributions. Nonparametric assessments were used when Shapiro-Wilk tests indicated that the assumptions of normality were violated. A Kruskal-Wallis test was used to examine differences among BMC, BMA, and Ficoll gradient samples with respect to adherent cell yield from in vitro assays, and paired t tests were used to assess differences between BMC and BMA in adherent cell yield as well as differences in morphological MRI scores and quantitative MRI values between different limbs within the same animal. Wilcoxon signed-rank tests were used to assess differences in arthroscopic and histological scores between paired limbs of the same animal from the different treatment groups.
Results

In Vitro Assays
T he mean total number of nucleated cells in BMA (± standard error of the mean) was 1.92 · 10 11 ± 2.64 · 10 10 and was reduced after processing into BMC (9.66 · 10 9 ± 2.37 · 10 9 ; p = 0.008 compared with BMA) or by Ficoll gradient isolation (7.32 · 10 8 ± 3.35 · 10 8 ; p = 0.008 compared with BMA). After plating and 14 days of culture, cell yields from BMC and Ficoll isolation were greater than from BMA (Kruskal-Wallis test, p = 0.004) (Fig. 1) . After culture expansion, BMC yielded 5.5 times more cells than BMA (paired t test, p = 0.005).
Fresh BMA, BMC, and Ficoll gradient isolated bone marrow cells did not undergo chondrogenesis in pellet culture. Culture-expanded cells from BMA, BMC, and Ficoll gradient preparations displayed trilineage differentiation (chondrogenic, osteogenic, and adipogenic potential). With respect to chondrogenesis, pellet size increased in response to TGF-b1 in all cultureexpanded cell groups, with no significant differences noted among the groups (Fig. 1) . Pellets from all culture-expanded cell groups exposed to TGF-b1 demonstrated positive safranin O-fast green staining (Fig. 1) and did not differ in Bern score (p > 0.05).
Arthroscopic Evaluation
Repair tissue was observed throughout the defect bilaterally in 6 of the 7 horses and filled at least 50% of the defect depth in 6 of 7 of the BMC repairs and in 5 of 7 of the microfracture repairs. One horse showed a sparse 25% repair in both defects. Mean ICRS scores did not differ between the microfracture and BMC groups (n = 7; mean of 6.7 ± 3.6 compared with 5.4 ± 2.0, respectively; Wilcoxon signed-rank tests, p = 0.22). The highest and lowest arthroscopic scores were in the microfracture group, where ICRS scores ranged from 2 to 12, with higher scores indicative of a better quality of repair (Fig. 2) . With respect to overall arthroscopic assessment, 3 of 7 repairs in the microfracture group were scored as "normal" to "nearly normal"; 2 of 7, "abnormal"; and 2 of 7, "severely abnormal." In the BMC group, 6 of 7 repairs were scored as "abnormal," and 1 repair, "severely abnormal."
Morphological MRI
Repair tissue was noted to have filled 67% to 100% of the defect in 2 of 7 microfracture repairs and 4 of 7 BMC repairs. Moderate to severe subchondral bone overgrowth was observed in 5 of 7 microfracture repairs and 2 of 7 BMC repairs. There was a trend toward less subchondral bone overgrowth after treatment with BMC compared with microfracture (mean grade, 1.6 ± 1.0 compared with 2.3 ± 1.0; paired t test, p = 0.09). Moderate to severe sclerosis was observed in 3 of 7 microfracture repairs and 1 of 7 BMC repairs. Synovial reaction was observed in 6 of 7 microfracture repairs and 4 of 7 BMC repairs. Synovial reaction was confined to the area of implantation, except in 1 microfracture case, which also showed synovitis cephalad to the repair site. The microfracture group showed worse overall MRI scores than did the BMC group (8.4 ± 1.8 compared with 6.3 ± 3.6; paired t test, p = 0.027), where higher scores reflect inferior joint outcomes (Table II) .
Quantitative MRI T2 (Fig. 3) and UTE-T2* MRI maps (Figs. 2 and 3) showed heterogeneous repair tissue patterns. Mean T2 and UTE-T2* values did not differ between the microfracture and BMC-treated Correlation 0.67 ± 0.12 0.58 ± 0.08 0.20 †GLCM= gray-level co-occurrence matrix. "Contrast" measures the amount of local T2 variation, "homogeneity" measures the T2 similarities between voxels and their neighbors, "correlation" measures linear dependencies of T2 values, and "energy" measures the orderliness of the T2 distribution 36 . ‡The values are given as the mean and the standard deviation. MFX = microfracture, and BMC = bone marrow concentrate. §Paired t test. #Significant.
repairs. No differences were observed in T2 texture statistics between microfracture and BMC (p ‡ 0.31) (Table III) . However, UTE-T2* texture statistics showed that BMC repairs had significantly greater contrast (p = 0.03), less homogeneity (p = 0.01), and less energy (p = 0.04) than microfracture repairs (Table III) .
Histological Assessment
Both the microfracture and BMC repairs showed fibrous to fibrocartilaginous tissues. Safranin O-fast green staining was qualitatively diminished in all repairs (Fig. 3) . No differences in ICRS histological scores were detected between the treatment groups for any individual criterion or total scores (Wilcoxon signed-rank tests, p > 0.17).
Discussion
T his study demonstrated that arthroscopic application of minimally manipulated autologous BMC directly to large, full-thickness chondral defects in an equine model resulted in repairs with fibrous to fibrocartilaginous tissues similar to those observed in microfractured defects at 1 year of follow-up. The in vitro data also showed that neither BMC nor BMA, which was tested as a surrogate for microfracture, contain notable amounts of mesenchymal stem cells. While the repair tissues within the cartilage defect appeared similar between groups, MRI assessment, in which the subchondral bone and synovium were also evaluated, showed better outcomes for the BMC group, suggesting a potential positive effect of reduced surgical trauma to the subchondral bone.
An important finding of this study was that neither cells from BMA nor cells from BMC prepared using a standard clinical system at the point of care underwent chondrogenesis in pellet culture. Neither BMA, tested as a surrogate for what can optimally be obtained from microfracture, nor BMC meet minimal criteria for characterization as mesenchymal stem cells (MSC). As defined by the International Society for Cellular Therapy (ISCT), "First, MSC must be plastic-adherent when maintained in standard culture conditions." 39 The remaining 2 minimal criteria describe specific surface molecules and the ability to differentiate into osteoblasts, adipocytes, and chondroblasts in vitro 39 . While few consider microfracture a stem-cell therapy, this outcome for BMC highlights the paucity of mesenchymal stem cells in minimally manipulated preparations that are not culture-expanded.
The data did show that, after culture expansion, BMC yielded higher concentrations of mesenchymal stem cells than did BMA. Culture-expanded cells from both BMA and BMC showed appropriate equine cell surface markers 23 and displayed trilineage potential, thereby meeting the ISCT criteria for mesenchymal stem cells. This study also showed that the plastic-adherent cells from both BMA and BMC had chondrogenic potential similar to that of adherent cells from traditional Ficoll gradient isolates. Taken together, our data suggest that BMC has a higher concentration of mesenchymal stem cells than unprocessed bone marrow accessible by marrow stimulation.
The current study protocol and outcomes differ from those of a previous equine study in which BMC augmentation of chondral defects treated with microfracture improved repair tissue quality compared with microfracture alone 23 . This prior positive outcome of BMC treatment suggests that other mechanisms in addition to the few mesenchymal stem cells in BMC, such as paracrine, anti-inflammatory, or immunomodulatory effects, may be responsible for tissue regeneration. Proteomic investigations of BMC have shown substantially increased levels of interleukin 1 receptor antagonist protein (IRAP) 40 , an anti-inflammatory mediator showing potential chondroprotective effects 41 . These potential effects of BMC and/or the presence of a hyaluronic acid scaffold may have also contributed to the results of a previous study in which BMC in a hyaluronic acid-based scaffold showed improved mediumterm outcomes compared with microfracture in humans 27 . Further research into BMC mechanisms is needed.
Although the small numbers in this hypothesisgenerating equine study substantially limit the generalizability of our findings, the comprehensive multidisciplinary assessments illustrate several important points applicable to human clinical study. First, the data provide information on the relative utility of arthroscopy, MRI, and quantitative MRI for evaluating the repair of large chondral defects that approach the size of clinically relevant lesions in humans. Each modality can be used to measure structural outcomes in a different fashion and on a different scale. Histological evaluation is destructive, severely limited in scope, and not clinically feasible. It did, however, provide detailed confirmatory information for small regions of interest. Macroscopic assessments by arthroscopy primarily showed the cartilage repair, and thus subchondral bone changes observable by MRI and histological evaluation were not well seen by arthroscopy. On the other hand, repair tissue surface fissuring that was detectable by arthroscopic and histological evaluation was not well visualized by MRI because of limitations imposed by slice thickness and partial volume effects (Fig. 3) .
Nevertheless, morphological and quantitative MRI offer several advantages for human clinical evaluation of cartilage repair. Being noninvasive and nondestructive, MRI can be readily employed for human clinical evaluations and for longitudinal studies. Quantitative MRI provides additional information on repair tissue matrix organization. The UTE-T2* metric is particularly sensitive to cartilage deep-tissue structure 42 . Differences in UTE-T2* GLCM texture statistics related to contrast, homogeneity, and energy suggestive of a more developed laminar structure parallel to the bone/repair interface in BMC-treated repairs may therefore reflect improved repair tissue organization related to reduced surgical trauma. This interpretation is supported by the findings of a study by Welsch et al., wherein matrix-associated autologous chondrocyte transplantation (MACT) showed zonal variations in T2 values while microfracture repairs did not 43 . The arthroscopic appearance of the repairs also provides insight into variable human clinical outcomes after microfracture 9, 15, 17, 19, 22, 44 . By arthroscopic evaluation, repairs with both the best and the worst appearance were in the microfracture group. If similar variability of this 1-year appearance among horses occurred in humans, the data suggest that some would likely do very well in early clinical follow-up while others would experience limited to no benefit.
The durability of the repair, however, may be affected by subchondral bone changes. While the sample size was small, morphological MRI in the present study showed outcomes suggestive of improved subchondral bone characteristics in the BMC repairs compared with the microfracture repairs. These data support continued efforts to minimize bone injury from marrow-stimulation procedures through the use of narrower awls or small-diameter drills 21, 45 or by the development of alternative treatment strategies.
In summary, this study showed that arthroscopic application of BMC to critical-sized chondral defects in an equine model resulted in fibrous to fibrocartilaginous repairs similar to repair by microfracture. While BMC treatment did not yield hyaline cartilage, MRI outcomes suggest less damage to the subchondral bone, potentially from reduced surgical trauma. The data also showed that there were not enough mesenchymal stem cells in minimally manipulated BMC to generate cartilaginous pellets in vitro. Thus, the finding of fibrous to fibrocartilaginous repairs observed in this study following BMC treatment should not be extrapolated to mean that mesenchymal stem cell therapies lack chondrogenic effect. Nevertheless, these results highlight the continued paucity of good options where no technology has yet convincingly replaced microfracture as a clinical standard. The continued development of strategies to promote in vivo chondroprogenitor cell differentiation remains critically important for advancing the clinical treatment of large, full-thickness chondral defects. n
